Consistent with these findings, we confirmed a higher frequency of somatic TP53 mutations and reduced miR-34a expression in SChigh HNSCC, while p53 pathway activity and miR-34a expression were higher in SClow tumors. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.